NDC 58198-0027 - Claro
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 58198-0027
- Package NDCs from labels
- 58198-0027-1, 58198-0027-2, 58198-0027-3, 58198-0027-4
- Manufacturer
- Elanco US Inc.
- Effective date
- 2025-07-22
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| CLARO™ Elanco TM (florfenicol, terbinafine, mometasone furoate) | Elanco US Inc. | 2025-07-22 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 58198-0027-1 | Claro | 1 mL in 1 TUBE, WITH APPLICATOR | SOLUTION | 1 | 6 | |
| 58198-0027-2 | Claro | 2 in 1 CARTON | SOLUTION | 2 | 6 | |
| 58198-0027-2 | Claro | 1 in 1 BLISTER PACK | SOLUTION | 1 | 6 | |
| 58198-0027-3 | Claro | 1 in 1 BLISTER PACK | SOLUTION | 1 | 6 | |
| 58198-0027-3 | Claro | 10 in 1 CARTON | SOLUTION | 10 | 6 | |
| 58198-0027-4 | Claro | 1 in 1 BLISTER PACK | SOLUTION | 1 | 6 | |
| 58198-0027-4 | Claro | 20 in 1 CARTON | SOLUTION | 20 | 6 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 58198-0027 | CLARO (FLORFENICOL, TERBINAFINE, MOMETASONE FUROATE) SOLUTION [ELANCO US INC.] | 5 | 7 package rows | 20231115_9bd1d059-68a6-459f-9f79-2fcd97c952d6.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Mometasone Furoate | MOMETASONE FUROATE | Sun Pharmaceutical Industries, Inc. | ce61920d-65df-4423-925d-091e624ea32e | 2025-07-07 | Warnings, Adverse reactions | 04201GDN4R |
| Mometasone Furoate | MOMETASONE FUROATE | Bryant Ranch Prepack | 43a91066-1d85-4f67-9856-a11c1bb2b22b | 2024-11-20 | Warnings, Adverse reactions | 04201GDN4R |
| Mometasone Furoate | MOMETASONE FUROATE | Bryant Ranch Prepack | 6c7d8133-b71e-4290-bec1-53ff0232998a | 2024-08-30 | Warnings, Adverse reactions | 04201GDN4R |
| Childrens Nasonex | MOMETASONE FUROATE | L. Perrigo Company | e15d055e-9a25-46b4-8724-3609cf2dc062 | 2024-08-28 | Warnings | 04201GDN4R |
| Mometasone Furoate | MOMETASONE FUROATE | Bryant Ranch Prepack | 45c9512b-9463-4684-bfdb-742644d77cc3 | 2024-08-14 | Warnings, Adverse reactions | 04201GDN4R |
| Mometasone Furoate | MOMETASONE FUROATE | Proficient Rx LP | 2bf06b19-4ed7-41a3-b6fc-29713c41965c | 2024-02-01 | Warnings, Adverse reactions | 04201GDN4R |
| Mometasone Furoate | MOMETASONE FUROATE | Cosette Pharmaceuticals, Inc. | f69603aa-a5a6-b8f3-c9ed-2d0abc9f4d92 | 2023-11-29 | Warnings, Adverse reactions | 04201GDN4R |
| Mometasone Furoate | MOMETASONE FUROATE | Cosette Pharmaceuticals, Inc. | f5b30e5e-b067-e28c-b7c5-aa58f4c57f09 | 2023-11-29 | Warnings, Adverse reactions | 04201GDN4R |
| Mometasone Furoate | MOMETASONE FUROATE | Bryant Ranch Prepack | c3053a64-9044-496e-9005-12b4440d46e8 | 2023-10-20 | Warnings, Adverse reactions | 04201GDN4R |
| Mometasone Furoate | MOMETASONE FUROATE | Bryant Ranch Prepack | d15edb8b-c8b2-4023-992e-f79cefa2d1e8 | 2023-08-16 | Warnings, Adverse reactions | 04201GDN4R |
| Mometasone Furoate | MOMETASONE FUROATE | Bryant Ranch Prepack | a6055a9c-e19c-48ad-a743-c0a7f7366cdd | 2023-07-18 | Warnings, Adverse reactions | 04201GDN4R |
| Mometasone Furoate | MOMETASONE FUROATE | Bryant Ranch Prepack | 5f1f2136-9e10-4d43-bb35-ed285c744fe4 | 2023-07-18 | Warnings, Adverse reactions | 04201GDN4R |
| Mometasone Furoate | MOMETASONE FUROATE | Padagis Israel Pharmaceuticals Ltd | 7296b4a2-f180-4887-a8e0-029f81aec566 | 2023-04-21 | Warnings, Adverse reactions | 04201GDN4R |
| Mometasone Furoate | MOMETASONE FUROATE | A-S Medication Solutions | 9fe65193-b4d8-480b-89b3-178cd1b20713 | 2023-02-15 | Warnings, Adverse reactions | 04201GDN4R |
| Sinuva | MOMETASONE FUROATE | Intersect ENT, Inc. | e33c1b23-cdc6-4f64-94ba-24b0b42c09bf | 2023-01-26 | Warnings, Adverse reactions | 04201GDN4R |
| Mometasone Furoate | MOMETASONE FUROATE | Proficient Rx LP | 47a60763-671e-413b-b962-f7f11ba2f4d7 | 2021-01-01 | Warnings, Adverse reactions | 04201GDN4R |
| Mometasone Furoate | MOMETASONE FUROATE | Glenmark Pharmaceuticals Inc., USA | 96eafc06-0354-49ca-a684-a77bb2afc8f5 | 2020-05-31 | Warnings, Adverse reactions | 04201GDN4R |
| Mometasone Furoate | MOMETASONE FUROATE | Proficient Rx LP | c08fcb0d-7fff-4d90-aeb8-e912b930bf3d | 2020-02-01 | Warnings, Adverse reactions | 04201GDN4R |
| Mometasone Furoate | MOMETASONE FUROATE | Glenmark Pharmaceuticals Inc., USA | 031283ed-988b-4698-8a2e-00f3d41c0f71 | 2019-07-09 | Warnings, Adverse reactions | 04201GDN4R |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.